Trials of BiTEs for the treatment of acute leukemias
What is the future of treating ALL?
Information is key: why patients need to be empowered to learn about their disease
Biosimilars and the future of more affordable treatment for hematologic malignancies
Using PET to determine treatment response in Hodgkin lymphoma